ArticleMicroorganisms2020
Steroid Derivatives as Potential Antimicrobial Agents Against
Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 38 citations in OpenAlex.
- In Vitro Antifungal Evaluation, GC-MS Profiling, and Molecular Docking of Eruca sativa Oil, Clove Oil, and Fusarium chlamydosporum Extract Against the Dermatophyte Trichophyton interdigitale.Current microbiology · 2026Article
- Unveiling the Therapeutic Spectrum of Annona reticulata Linn.: Antibacterial, Insecticidal, and Antidiarrheal Insights.TheScientificWorldJournal · 2026Article
- Integrated Morphoanatomical, Phytochemical, and Bioactive Insights Into the Ethnomedicinal Plant Daphniphyllum neilgherrense.Chemistry & biodiversity · 2026Article
- Evaluation of the antibacterial potential in shoot and root extracts of Eryngium campestre with emphasis on Egyptian ecotype.Scientific reports · 2025Article
- Impact of Fermentation on Bacterial and Fungal Microbiome Interactions inInternational journal of food science · 2025Article
- Assessing the Potential ofACS pharmacology & translational science · 2024Article
- Antibacterial activity of Shallots (Iranian journal of microbiology · 2024Article
- GC-MS, Antibacterial and In silico Studies of SudaneseJournal of experimental pharmacology · 2024Article
- Article
- PYED-1 Overcomes Colistin Resistance inPathogens (Basel, Switzerland) · 2023Article
- Cladophora glomerata extracts produced by Ultrasound-Assisted Extraction support early growth and development of lupin (Lupinus angustifolius L.).Scientific reports · 2023Article
- Delving into the Mechanisms of Sponge-AssociatedMolecules (Basel, Switzerland) · 2023Article
- 6-Polyaminosteroid Squalamine Analogues Display Antibacterial Activity against Resistant Pathogens.International journal of molecular sciences · 2023Article
- Hormonal drugs: Influence on growth, biofilm formation, and adherence of selected gut microbiota.Frontiers in cellular and infection microbiology · 2023Article
- Antimicrobial and Antibiofilm Effect of 4,4'-Dihydroxy-azobenzene against Clinically Resistant Staphylococci.Antibiotics (Basel, Switzerland) · 2022Article
- Attenuating the virulence of the resistant superbug Staphylococcus aureus bacteria isolated from neonatal sepsis by ascorbic acid, dexamethasone, and sodium bicarbonate.BMC microbiology · 2022Article
- Methods for Rapid Screening of Biologically Active Compounds Present in Plant-Based Extracts.Molecules (Basel, Switzerland) · 2022Article
- The inhibitory effect of some pyrazole ligands and their Cu(II) complexes on the growth ofFrontiers in pharmacology · 2022Article
- The Potential of 24-Propylcholestrol as Antibacterial Oral Bacteria ofAdvances and applications in bioinformatics and chemistry : AABC · 2022Article
- The Glucocorticoid PYED-1 Disrupts Mature Biofilms ofAntibiotics (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this work, the antibacterial activity of deflazacort and several of its synthetic precursors was tested against a panel of bacterial pathogens responsible for most drug-resistant infections including
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.